Pamela Ling, MD
Tobacco industry marketing strategies targeting young adults, women, and other high risk population, and new smokeless and novel tobacco product marketing strategies with focus on how to use tobacco industry marketing strategies to improve tobacco control programs.
Ruth Malone, RN, PhD, FAAN
Tobacco industry activities aimed at undermining public health, strategic positioning and messaging, marginalized populations, and emerging developments in the social construction of tobacco use.
Jyothi Marbin, MD
Impact of tobacco on low income, urban children and reducing the burden of secondhand smoke on children with focus on the impact of electronic health record changes on clinical uptake of tobacco cessation interventions, as well as the use of online trainings to train physicians on smoking cessation.
Gregory Marcus, MD, MAS
Cardiovascular effects of alcohol, atrial fibrillation, supraventricular, implantable cardiac devices with broader interests in clinical research study design and genetic epidemiology.
Michael Matthay, MD
Effects of cigarette smoke and e-cigarette aerosols on susceptibility to acute respiratory distress syndrome (ARDS), a major cause of respiratory failure in critically ill patients.
Wendy Max, PhD
Economic impact of tobacco on health and healthcare expenditures.
Dieter Meyerhoff, PhD
Defining a new MR spectroscopy-based in vivo biomarker of cerebral oxidative stress, which has been associated with chronic smoking and other substance dependence.
Jeremiah Mock, MSc, PhD
Dr. Mock conducts collaborative research examining how people’s cultural context shapes their patterns of tobacco use. As a health anthropologist, for over two decades he has focused on examining how and why people’s lived experience of tobacco use and secondhand smoke exposure is deeply rooted in culture, and how cultural and political-economic change can influence the prevalence of tobacco use within a cultural group, as well as changes in people’s modes and norms of tobacco use. His work has recently expanded to examine the cultural phenomena of young people’s pod-based e-cigarette use (e.g., “juuling”), heated tobacco product (e.g., IQOS) use, and cannabis use.
Pages
Center Leadership
Pamela Ling, MD MPH
Director, Center for Tobacco Control Research & Education
Fellowship Program Director
Scarlett Lin Gomez, MPH, PhD
Co-Director, Helen Diller Comprehensive Cancer Center Cancer Control Program
Tung T. Nguyen, MD
Co-Director, Helen Diller Comprehensive Cancer Center Cancer Control Program
Research Spotlight
We are studying the effects of both active smoking and secondhand smoke exposure on susceptibility to acute lung injury, a major cause of respiratory failure among critically ill patients.
